Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Signs Three Network Provider Agreements

NEW YORK (GenomeWeb) – Cancer Genetics today announced that is has signed in-network provider agreements with Blue Cross Blue Shield (BCBS) of North Carolina, BCBS Nebraska, and WellMark.

The deals open up the firm's molecular diagnostic testing to a combined customer base of 6.7 million people, Cancer Genetics said in a statement.

"Developing relationships with leading regional and national payer organizations is central to our strategy," Randy Goodman, director of reimbursement and clinical revenue cycle management at Cancer Genetics, said in a statement. "CGI's new agreements with these three providers represent a significant milestone in our larger corporate strategy, which is geared toward increasing health plan reimbursement for our genomic testing platforms and offering our services to a wider patient community."

WellMark comprises the BCBS networks in Iowa and North Dakota. The provider agreements are the latest in a series of agreements with payors for Cancer Genetics, including recent deals to provide testing services to BCBS of Illinois, Harvard Pilgrim Healthcare, and America's Choice Provider Network.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.